À retenir
Among 278 adults with obesity at 10 Oxfordshire practices, a total diet replacement programme gave weight change of -10.7 kg at 12 months versus -3.1 kg with usual care (adjusted mean difference -7.2 kg, 95% CI -9.4 to -4.9). Only 73% were re-measured at 12 months, and the trial was open label, so participants and staff knew who got which programme.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Very low calorie formula diets can produce large weight loss, but it is unclear whether they work in ordinary primary care. The authors tested the effectiveness and safety of a total diet replacement (TDR) programme for routine obesity treatment.
Population et méthode
Pragmatic, open-label, two-arm randomised controlled trial in 10 primary care practices in Oxfordshire, UK. 278 adults with obesity who wanted to lose weight were assigned to TDR (138) or usual care (140). TDR meant weekly behavioural support for 12 weeks and monthly support for three months, with formula food providing 810 kcal/day as the only food for the first eight weeks, then food reintroduced. Usual care was behavioural support from a practice nurse plus a diet programme with modest energy restriction. The primary outcome was weight change at 12 months, analysed by intention to treat with mixed effects models; secondary outcomes included cardiovascular and metabolic biomarkers, and adverse events were recorded.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Weight change at 12 months was -10.7 kg with TDR and -3.1 kg with usual care, an adjusted mean difference of -7.2 kg (95% CI -9.4 to -4.9).
- 245% of the TDR group lost 10% or more of their weight, compared with 15% of the usual care group.
- 3The TDR group showed greater improvements in cardiovascular and metabolic risk biomarkers; the abstract does not give the individual values.
- 4Adverse events of moderate or greater severity occurred in 11% of the TDR group and 12% of the usual care group.
Limites et incertitude
- 1Only 73% of participants were re-measured at 12 months, so some weights are missing and results depend on how missing data were handled.
- 2The trial was open label, so participants knew their programme, which can influence motivation and reporting.
- 3Follow-up was 12 months, so it cannot show whether the weight loss lasts longer or what happens to heart disease or diabetes outcomes.
- 4This reading is based on the abstract only.
Mise en perspective
In this trial, a structured 810 kcal/day formula programme with behavioural support led to clearly more weight loss than nurse-led usual care and did not have more moderate or severe adverse events. A diet this low in calories is a medical decision, so anyone interested should discuss it with their doctor or practice nurse rather than starting alone.
Vos données
Weekly weigh-ins on the same scale, at the same time of day, show the trend better than single readings. If you track blood pressure, blood glucose or waist size, compare each only with your own earlier readings under the same conditions.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Objective
To test the effectiveness and safety of a total diet replacement (TDR) programme for routine treatment of obesity in a primary care setting.
Design
Pragmatic, two arm, parallel group, open label, individually randomised controlled trial.
Setting
10 primary care practices in Oxfordshire, UK.
Participants
278 adults who were obese and seeking support to lose weight: 138 were assigned to the TDR programme and 140 to usual care. 73% of participants were re-measured at 12 months.
Interventions
The TDR programme comprised weekly behavioural support for 12 weeks and monthly support for three months, with formula food products providing 810 kcal/day (3389 kJ/day) as the sole food during the first eight weeks followed by reintroduction of food. Usual care comprised behavioural support for weight loss from a practice nurse and a diet programme with modest energy restriction.
Main outcome measures
The primary outcome was weight change at 12 months analysed as intention to treat with mixed effects models. Secondary outcomes included biomarkers of cardiovascular and metabolic risk. Adverse events were recorded.
Results
Participants in the TDR group lost more weight (-10.7 kg) than those in the usual care group (-3.1 kg): adjusted mean difference -7.2 kg (95% confidence interval -9.4 to -4.9 kg). 45% of participants in the TDR group and 15% in the usual care group experienced weight losses of 10% or more. The TDR group showed greater improvements in biomarkers of cardiovascular and metabolic risk than the usual care group. 11% of participants in the TDR group and 12% in the usual care group experienced adverse events of moderate or greater severity.
Conclusions
Compared with regular weight loss support from a practice nurse, a programme of weekly behavioural support and total diet replacement providing 810 kcal/day seems to be tolerable, and leads to substantially greater weight loss and greater improvements in the risk of cardiometabolic disease.
Trial registration
International Standard Randomised Controlled Trials No ISRCTN75092026.
Sources et attribution
Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET): pragmatic randomised controlled trial.
Astbury NM, Aveyard P, Nickless A, Hood K, Corfield K, Lowe R, Jebb SA.
BMJ (Clinical research ed.) · 2018-09-26
DOI: 10.1136/bmj.k3760 ↗PubMed · 30257983 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

